Why Quality Matters in ART Programs

Slides:



Advertisements
Similar presentations
Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.
Advertisements

Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Dr Tin Tin Sint Department of HIV/AIDS World Health Organization
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) HIV Prevention Training Package Session 1: Introduction.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
AIDS Turning the Tide Together IAS Satellite: Where the Tide Will Turn: How is Community Level Participation Most Effective in Turning the Tide?
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
ART Regimen Selection and Treatment Initiation for PMTCT Programs Lara Stabinski, MD, MPH Medical Officer Clinical Services S/GAC June 18, 2012.
ANC-HIV INTEGRATION Countdown to zero; is it time for a gear shift? Dr Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD PGD (Research Ethics) Deputy.
Child Health: How Have We Been Doing; Where to Now? An Update on MDG 4 and 5: Maternal and Child Health By Dr. Mickey Chopra, Chief, Health and Associate.
The Strategic Use of ARVs | IAC Satellite, July 22, |1 | Strategic Use of Antiretroviral Drugs WHO Perspective for Future Guidelines Chair of WHO.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Management and Development for Health (MDH)
Resource Needs Model Rachel Sanders October 28 th, 2010.
Life expectancy of patients treated with ART in the UK: UK CHIC Study Margaret May University of Bristol, Department of Social Medicine, Bristol.
Edward Mills PhD, Associate Professor, Faculty of Health Sciences University of Ottawa AIDS Mortality Among Men in Africa: An overview of the evidence.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
Health system design priority IS questions Margaret E. Kruk, MD, MPH Associate Professor of Global Health Harvard T.H. Chan School of Public Health.
Strengthening Integration between RMNCH and HIV services Nuhu Yaqub WHO Tanzania.
Successfully enrolled in HIV Care but not linked to timely Treatment: Poor retention and Monitoring of Pre-ART patients who are not yet eligible for ART.
Date of download: 6/23/2016 From: The Anticipated Clinical and Economic Effects of 90–90–90 in South Africa Ann Intern Med. Published online May 31, 2016.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
#AIDS2016 Superior Outcomes with Same-Day HIV Testing and ART Initiation Serena Koenig, MD, MPH GHESKIO, Haiti Brigham and Women’s Hospital,
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Treatment as prevention: policy and programmatic considerations
Outline The Global Fund Strategy emphasizes the Key Populations
New WHO Guidelines on Person centred monitoring
PRESENTED AT THE 9TH IAS CONFERENCE ON HIV SCIENCE - PARIS, FRANCE
Amir Shroufi Medical Coordinator MSF South Africa
How differentiated care supports “Tx all” and Dr
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
Contents Global impact 2.Service cascade 3. Policies and WHO support.
System Capacity and Population Need May 9, 2017
Pregnancy and living with HIV
Number of people receiving antiretroviral therapy in
WHO strategy on HIV/AIDS “Getting to Zero”
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Differentiated Service Delivery: Innovating for Impact
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
Continuum of HIV Care, Treatment, and Prevention
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
XVI I IAC Mexico 3-8 August 2008 Txema Calleja WHO/OMS
Ambassador Deborah L. Birx, MD
World Health Organization
The Last Mile to EMTCT: Are we there yet?
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Andrew Lofts Gray Division of Pharmacology
Tiffany G. Harris, PhD, MS Director of Strategic Information
The role of CD4 in patient monitoring Amsterdam July 2018
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
Patrick Brenny, UNAIDS RST-WCA
Fatima Oliveira Tsiouris Deputy Director, Clinical & Training Unit
July 21, 2016 Potential Domestic Source Financing for Scaled Up Antiretroviral Therapy in 97 Countries, 2016–2020 Arin Dutta, Catherine Barker, and Ashley.
From toward HIV Elimination with Boosted-Integrated Active HIV Case Management (B-IACM) in Cambodia Dr. Penh Sun LY, Director, NCHADS Presented.
Management and Development for Health (MDH)
Contents Global impact 2.Service cascade 3. Policies and WHO support.
TB Screening and Differentiated Service Delivery: State of the Art
CQUIN Call to Action Peter Preko MB, ChB Project Director, CQUIN
Jessica Justman, MD Senior Technical Director ICAP at Columbia
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Why Quality Matters in ART Programs Charles B. Holmes, MD, MPH Georgetown University Center for Global Health Practice and Impact & Johns Hopkins School of Medicine #IAS2019 Satellite: Addressing the quality gap within HIV programmes

Outline How is impact achieved? Elements of quality HIV services New WHO Quality Technical Brief Ensuring care is people-centered- measuring the patient experience The link between quality care and drug resistance Conclusions

When you look at this curve, what comes to mind? UNAIDS, 2018

What comes to mind? Clinical Quality? UNAIDS, 2018

Quality care and mortality Longitudinal survival analysis of the (US) Veterans Aging Cohort Study included 3038 people living with HIV Korthuis et al, CID 2016

Quality indicators associated w/decreased mortality Overall, receiving ≥80% of eligible QIs was associated with a 25% decrease in mortality rate compared with receiving a lower percentage of eligible QIs (age-adjusted hazards ratio, 0.75; 95% confidence interval, .65–.86). Korthuis et al, CID 2016

WHO advanced care guidelines For adults, adolescents, and children ≥ 5 years, advanced HIV disease is defined as a CD4 cell count <200 cells/mm3 or a WHO clinical stage 3 or 4 event at presentation for care Estimates of eligibility in LMIC for the advanced care package range from 15-30% depending on the setting

Quality of care for patients with advanced disease? Show of hands for current coverage of advanced disease package in LMIC: 10% 46% 81% The Answer? We don’t know

Access x Quality = Impact

Access? Is our treatment scale-up slowing down?

Access? But maybe we’re differentially missing sub-groups with higher mortality Treatment scale-up is continuing apace Children Sex workers Conceivable that poor access among people at highest risk for mortality… UNAIDS, 2019

Upstream quality affects downstream access If we’re differentially “missing” individuals at high risk for mortality, we have an upstream quality problem It could be that existing testing programs are settling for numbers or yield, but not effectively reaching the highest risk individuals (a quality issue in testing program) It could also be that the services for FSW or for children are insufficiently person-centered and do not retain people in care (a quality issue in the care delivery program) From a public health perspective, ACCESS at any step of the cascade is a partly a function of upstream QUALITY and ACCESS

Access x Quality = Impact

Upstream quality affects access and impact Prevention Access x quality Testing Better upstream quality in testing programs (e.g., not overlooking those at greatest risk for mortality - or transmission)… Access x quality Linkage and treatment initiation Access x quality Advanced care package And so on throughout the cascade Access x quality Retention Access x quality …results in greater access to/utilization of HIV care and treatment Virological suppression Access x quality Quality upstream in the public health cascade contributes to later access to service = Impact

5 million ‘excess’ deaths due to poor quality care in LMIC in 2016 Mortality due to poor quality versus non-utilisation of health care by condition type 5 million ‘excess’ deaths due to poor quality care in LMIC in 2016 Kruk et al, Lancet 2018

What do quality HIV services look like?

WHO Technical Brief on Quality of HIV Care, 2019

“Quality HIV services span not only clinical, but health systems and other service delivery components and settings across cascades of HIV prevention, care and treatment services as well as maternal, newborn and child health.” WHO Technical Brief on Quality of HIV Care, 2019

WHO: Enablers of Quality HIV Services

How do we ensure delivery of people-centered quality health services?

- Lancet Commission on Quality Health Systems “Health systems should measure and report what matters most to people, such as competent care, user experience, health outcomes, and confidence in the system” - Lancet Commission on Quality Health Systems Kruk et al, Lancet 2018

Understanding patient preferences is an important part of ensuring people-centered care &quality service delivery This can be done broadly, or among enriched sub-sets of patients Study conducted in Zambia to better understand the health systems preferences of those who had disengaged from care - with the goal of adjusting elements of the health system to better accommodate their needs and improve quality Sought a random sample of HIV patients who were lost to follow-up from treatment facilities in Lusaka Province, Zambia.  Zanolini, PLOS Med 2018

Preferences for HIV care among the lost Survey offered to 385 LTFU individuals, and 280 participated (average age 35; 60% females) Willingness to wait analysis suggested that patients would trade up to 19 hours of waiting time to access a facility with nice as opposed to rude providers. A willingness to travel analysis suggested that patients were willing to travel an extra 45 km to see a nice as opposed to a rude provider Zanolini, PLOS Med 2018

How can we improve the patient experience and health outcomes? “In addition to current improvement efforts to increase drug dispensation, move services closer to home, and extend hours (through DSD models), a concomitant effort to improve healthcare worker attitude has not been undertaken but may represent a high priority.” Requires systematic measurement of patient experience, provider morale and satisfaction Likely requires ongoing training and support for providers that enables them to enhance their practice of person-centered care, along with feedback of actionable data to site-and higher level decision-makers. Ongoing Patient-Centered Public Health (PCPH) study in Zambia - a stepped wedge study testing these combined strategies Zanolini, PLOS Med 2018

What’s the link between quality HIV services and prevention of drug resistance? “Preventing HIV drug resistance is critical for the success of any HIV treatment programme and is achieved by optimizing the quality of antiretroviral therapy services and eliminating programmatic gaps along the cascade of HIV treatment.”

Conclusions Quality upstream in the public health cascade helps to determine later access to service- quality is therefore an essential part of access and impact National quality programs promote actions at all levels of the health system Patient preferences/experience should be measured within HIV programs, and are essential to tailoring services to become more person-centered Prevention of HIV drug resistance relies on quality delivery of health services (more to come from Sylvia)